Hirokazu Takami

20PUBLICATIONS
25CO-AUTHORS
Gene expression (incl. microarray and other genome-wide approaches)Cancer therapy (excl. chemotherapy and radiation therapy)Medical infection agents (incl. prions)Central nervous systemPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Sep 29, 2026
Spatial transcriptomic analysis of neurons at the glioma infiltration front: A case study.

|Jul 11, 2025
Dissecting the Immunological Microenvironment of Glioma Based on IDH Status: Implications for Immunotherapy.

Miyu Kikuchi, Hirokazu Takami, Yukari Kobayashi

|Nov 04, 2024
Phase II trial of pathology-based tripartite treatment stratification for patients with CNS germ cell tumors: A long-term follow-up study.

Hirokazu Takami, Masao Matsutani, Tomonari Suzuki

|Mar 04, 2024
Region-specific DNA hydroxymethylation along the malignant progression of IDH-mutant gliomas.

Taijun Hana, Akitake Mukasa, Masashi Nomura

|Sep 11, 2023
Intraventricular central neurocytoma molecularly defined as extraventricular neurocytoma: a case representing the discrepancy between clinicopathological and molecular classifications.

Daisuke Sato, Hirokazu Takami, Shunsaku Takayanagi

|Mar 30, 2023
Impact of tumor markers on diagnosis, treatment and prognosis in CNS germ cell tumors: correlations with clinical practice and histopathology.

Hirokazu Takami, Christopher S Graffeo, Avital Perry

Pageof 4

Frequent Collaborators

5 joint publications

Motoo Nagane

4 joint publications

Yoshitaka Narita

3 joint publications

Koichi Ichimura

2 joint publications

Yosuke Kitagawa